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Abstract
Background: The aim of this study is to report the outcome after surgical treatment of 32
patients with ampullary cancers from 1990 to 1999.
Methods: Twenty-one of them underwent pancreaticoduodenectomy and 9 local excision of the
ampullary lesion. The remaining 2 patients underwent palliative surgery.
Results: When the final histological diagnosis was compared with the preoperative histological
finding on biopsy, accurate diagnosis was preoperatively established in 24 patients. The hospital
morbidity was 18.8% as 9 complications occurred in 6 patients. Following local excision of the
ampullary cancer, the survival rate at 3 and 5 years was 77.7% and 33.3% respectively. Among the
patients that underwent Whipple's procedure, the 3-year survival rate was 76.2% and the 5-year
survival rate 62%.
Conclusion: In this series, local resection was a safe option in patients with significant co-
morbidity or small ampullary tumors less than 2 cm in size, and was associated with satisfactory
long-term survival rates.
Background
Carcinoma of the ampulla of Vater is an entity distinct
from neoplasms arising from the periampullary area.
Ampullary cancer accounts for some 7% of peripancreatic
tumors. It is less aggressive and has a better survival than
carcinomas arising from the pancreas or common bile
duct [1,2]. The 5-year survival rate reported after Whip-
ple's resection for ampullary cancer varies from 22% to
55% [3,4], whereas the relevant rate for pancreatic carci-
noma is reported not to be higher than 22% to 26% [5].
Even though the outcome of patients after resection of
ampullary cancer is more favorable, almost half of them
will die from tumor recurrence [6]. On the other hand,
pancreaticoduodenectomy has been reported to result in
Published: 30 August 2005
International Seminars in Surgical Oncology 2005, 2:16 doi:10.1186/1477-7800-
2-16
Received: 25 May 2005
Accepted: 30 August 2005
This article is available from: http://www.issoonline.com/content/2/1/16
© 2005 Botsios et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.International Seminars in Surgical Oncology 2005, 2:16 http://www.issoonline.com/content/2/1/16
Page 2 of 6
(page number not for citation purposes)
morbidity of 43% and mortality of 11% [7]. This fact has
led to interest in local resection of ampullary tumors as
described by Halstead in 1899 [8]. After local resection, it
has been reported that the mortality rate reaches 7.1% and
the 5-year survival rate 35% [9].
We report the outcome after surgical treatment of patients
with cancer of the ampulla of Vater, with Whipple's pro-
cedure, local resection or palliative by-pass surgery.
Methods
From 1990 to 1999, 205 patients diagnosed with periam-
pullary neoplasms were treated in our Department. Our
study population consisted of 32 of these patients that
proved to have carcinoma of the ampulla of Vater, and
underwent surgical treatment. They comprised 18 (56%)
men and 14 (44%) women of mean age 68.5 (range: 42–
77) years.
Only lesions confined to the ampulla or clearly invading
the surrounding tissues from the ampulla were designated
as ampullary carcinomas. Eight patients who were found
histologically to have ampullary adenomas were excluded
from the study as our aim was to focus on the outcome of
patients with malignant lesions of the ampulla of Vater.
All the patients underwent standard diagnostic imaging
investigations, which included conventional ultrasonog-
raphy (US), computed tomography (CT) scan and endo-
scopic retrograde cholangiopancreaticography (ERCP)
with multiple biopsies taken from the ampulla of Vater.
Thirty (30) of the 32 patients underwent potentially radi-
cal surgery: 21 underwent pancreaticoduodenectomy
(Whipple's procedure) and 9 local excision of the ampul-
lary lesion. The remaining 2 patients underwent palliative
surgery and particularly choledochojejunostomy Roux en
Y. No patient received adjuvant chemotherapy or radio-
therapy in the post-operative period. During the same
time period, 9 patients with non-resectable ampullary
cancer were not fit for operation and were treated with
ERCP and stent placement. These patients that did not
undergo surgical treatment were also excluded from the
study. None of them received adjuvant chemotherapy or
radiotherapy in the post-operative period, as well.
Pancreaticoduodenectomy was the first choice as the type
of surgical treatment. Local resection was the preferable
treatment when the ampullary lesion was less than 2 cm
in diameter, the pre-operative biopsy showed a pT1 cancer
or adenoma of the ampulla of Vater and/or the patient's
concomitant medical illness or age contraindicated a
major operation such as Whipple's procedure. Finally,
palliative by-pass surgery was reserved for patients whose
tumor was larger than 5 cm according to the findings of
the preoperative imaging investigations, obstruction of
the portal vein, invasion of the superior mesenteric artery
and/or vein, metastatic liver disease or distant metastases.
All patients underwent regular follow-up examinations
post-operatively on a 3-month basis for the first year, on a
6-month basis for the following 4 years, and annually
thereafter. Follow-up included clinical examination,
blood tests (CA 19-9, serum bilirubin, alkaline phos-
phatase), abdominal ultrasound and chest radiography.
The statistical methods employed were Fisher's exact test
for comparison of proportions. Differences among groups
with respect to continuous variables were tested using the
Kruskal-Wallis test, whereas pairwise differences were
compared by the Mann-Whitney test, at a Bonferroni-
adjusted significance level. The survival curves among
groups were compared with the Log-rank test and they
were presented graphically with the Kaplan-Meier plots.
Analyses were conducted in SPSS 11.0 (SPSS, Inc., Chi-
cago, IL). All reported p-values are two-tailed.
Results
All tumors were adenocarcinomas originating in the
ampulla of Vater. The median size of the tumors as meas-
ured by the pathologist was 2.9 (0.8–5.1) cm. The tumor
grade was recorded as well differentiated in 10, moder-
ately differentiated in 13 and poorly differentiated in 9
patients including the two patients with unresectable
tumors, according to pre-operative biopsy. Nodal involve-
ment was microscopically found in 14 (46.6%) patients.
The tumor was classified as pT1 in 8 patients and pT2-T4
in the remaining 22 patients with resectable tumors. All
patients with pT1 tumors underwent local excision, while
all patients with pT2-T4 tumors underwent pancreati-
coduodenectomy, except one who underwent local
excision.
When the final histological diagnosis after surgical treat-
ment was compared with the preoperative histological
finding on biopsy, accurate diagnosis was preoperatively
established in 24 patients. In the remaining patients, the
diagnosis was established intra-operatively by examina-
tion of frozen section in 3, and post-operatively by exam-
ination of the specimen in 3 patients.
The in-hospital, as well as the 30-day overall mortality
rate, was 0% as no death occurred among the patients of
the study. The overall hospital morbidity was 18.8%, as 9
complications occurred in 6 patients post-operatively. All
the complications occurred in patients who underwent
pancreaticoduodenectomy resulting in a morbidity of
28.6% in this group of patients. Although this morbidity
was substantially higher compared to the group undergo-
ing local excision and palliative surgery, this difference
was not statistically significant (p = 0.129, Table 1).International Seminars in Surgical Oncology 2005, 2:16 http://www.issoonline.com/content/2/1/16
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In particular, one patient presented with moderate leak-
age of the choledochojejunostomy, which was treated
conservatively. Pancreatic fistulas were seen in two
patients, which were also treated conservatively. One
patient developed a sub-hepatic abscess on the 20th post-
operative day, but ultrasound-guided drainage was ade-
quate treatment in this case. Surgical intervention was
required in a patient who presented with intra-abdominal
bleeding due to septic erosion of gastro-duodenal artery
and rupture of the pancreatojejunostomy and choledo-
chojejunostomy on the 13th post-operative day. Re-opera-
tion in this case included ligation of gastro-duodenal
artery, reconstruction of choledochojejunostomy and
drainage of the ruptured pancreatojejunostomy. The post-
operative period in this case was uneventful while the
pancreatic fistula subsided within two months. Finally,
two patients experienced moderate wound infection and
drainage of the wound abscess was adequate treatment in
these cases. On the other hand, the post-operative course
was uneventful in patients who underwent either local
excision or palliative operation.
Seventeen (17) patients have died during follow-up, and
all but three died because of recurrence. Following pallia-
tive operation (choledochojejunostomy Roux en Y), both
patients died 7 and 13 months after operation. Following
local excision of the ampullary cancer in 9 patients, the
survival rate at 3 years was 77.7% (7 patients) and 33.3%
(3 patients) at 5 years. In the patients that achieved 5-year
survival after local excision the resection was R0, the
tumor was graded as pT1, N0, M0 and, moreover, it was
well-differentiated.
Among 21 patients that underwent Whipple's procedure,
the 3-year survival rate was 76.2% (16 patients) and the 5-
year survival rate was 62% (13 patients). One patient is
alive 10 years after the operation and considered cancer
free. As shown in Figure 1, the median survival after Whip-
ple's procedure was significantly higher than the median
survival after local resection (65.2 vs. 38.6 months, p <
0.001).
The overall median hospital stay was 13.5 (range: 7–32)
days. The median in-patient stay after Whipple's proce-
dure was significantly greater than the median in-patient
stay after local excision and palliative operation (16 vs. 8
and 7.5 days respectively, p < 0.001, Table 1).
Discussion
Periampullary pancreatic neoplasms rank as the fifth lead-
ing cause of cancer death behind lung, breast, colorectal
and prostate cancer, causing more than 30,000 deaths per
year in the United States [10]. Ampullary carcinomas
account for 6%–20% of all periampullary tumors and for
10.2%–36% of all operable pancreatoduodenal neo-
plasms [2,3,11]. They account for about 0.2% of all gas-
trointestinal malignancies, with a median incidence of
about 57 cases per million of population per year [12,13].
In our study, cancer of the ampulla of Vater represented
15.6% of all periampullary carcinomas treated during the
same time period in our Department.
A major problem in dealing with ampullary tumors is to
differentiate between an adenoma and a carcinoma. Mod-
ern imaging studies such as US, CT scan, magnetic reso-
nance imaging (MRI) and magnetic resonance
cholangiopancreaticography (MRCP), have significantly
improved the diagnostic accuracy in the pre-operative
period. Moreover, endoscopic diagnostic techniques, such
as duodenoscopy with multiple biopsies and endoscopic
ultrasonography are extremely helpful tools in order to
determine the nature and the extend of the tumor pre-
operatively. However, despite the fact that endoscopic
ultrasonography may be helpful in detecting the invasion
of the tumor into the surrounding tissues and the occur-
rence of lymph node enlargement, it does not allow differ-
entiation between an adenoma and a pT1 carcinoma [14].
Furthermore, duodenoscopy with multiple biopsies has
been reported to miss the diagnosis of malignancy in 12%
to 40% of cases [15]. Because a negative biopsy does not
exclude the presence of an invasive carcinoma within the
adenoma, complete excision has been recommended in
all cases [16]. The above-mentioned recommendation
was also the policy in our study, as we performed either
Table 1: Comparison of different parameters among the different surgical approach groups.
Whipple's procedure (n = 21) Local excision (n = 9) Palliative surgery (n = 2) p-value
Hospital morbidity
n (%) 6 (28.6) 0 (0) 0 (0) 0.129a
Hospital stay, days
Median (range) 16 (9–32) 8 (7–10) 7.5 (7–8) <0.001b
a Fisher's exact test
b Kruskal-Wallis test for the overall comparison (The significant pairwise comparisons with Bonferroni adjusted p-value were Whipple's procedure 
vs. the other two groups for both the hospital stay and operation time [p < 0.05]).International Seminars in Surgical Oncology 2005, 2:16 http://www.issoonline.com/content/2/1/16
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Whipple's resection or local excision in all cases with a
resectable ampullary tumor. In our series, duodenoscopy
with biopsies failed to reveal malignancy in 20% of the
patients. Endoscopic ultrasonography was not included in
our diagnostic procedure due to lack of experience and
relevant equipment.
Options for excision of ampullary carcinomas include
local excision and pancreaticoduodenectomy. Halsted
performed the first local excision for ampullary carcinoma
in 1899 [8]. Although there are many case reports and a
few series on the treatment of ampullary neoplasms by
local ampullary resection, the criteria used to decide when
local excision is suitable for certain patients are controver-
sial, and not well addressed. For small lesions, thought to
be benign pre-operatively according to endoscopic
appearance and biopsy, ampullary resection is generally
well accepted [17]. Bottger et al [18] stated that the indi-
cations for local excision should be that the tumor is com-
pletely removed (R0), limited to the ampulla of Vater
(pT1), not poorly differentiated and with no venous/lym-
phatic infiltration in patients with ASA grade IV, regard-
less of their age. Similarly, Beger et al [19] reported that
local resection is indicated in cases with pT1, N0, M0 can-
cer of the ampulla of Vater, excluding patients with tumor
poorly differentiated. Moreover, he stated that if intra- or
even post-operative histological findings show a cancer
more advanced than pT1, node-positive, or poorly differ-
entiated tumor, the procedure should be extended to a
pancreaticoduodenectomy and that in patients with pT1
cancer, local excision should be always combined with a
local lymph node dissection. Regarding age as an indica-
Time to death for patients who underwent pancreaticoduodenectomy, local excision and palliative surgery Figure 1
Time to death for patients who underwent pancreaticoduodenectomy, local excision and palliative surgery. Log-rank test p < 
0.001.International Seminars in Surgical Oncology 2005, 2:16 http://www.issoonline.com/content/2/1/16
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tion for local excision, we can only analyze the reported
evidence about age as a contraindication for Whipple's
procedure. In many authors opinion, there is rarely any
justification for performing major resection in a patient
over 75 years of age due to high morbidity and mortality,
as well as short survival [20]. However, Kairaluoma et al
[21] suggested that age is not a limiting factor for pancre-
atic resection and it can be performed with acceptable sur-
vival rates even in patients over 70 years of age. In general,
local ampullary resection is accompanied by significantly
less morbidity and mortality than pancreaticoduodenec-
tomy [19,22]. In our study, mortality as well as morbidity
was 0% among 9 patients that underwent local excision
for ampullary cancer. Our criteria for performing local
excision were tumor size less than 2 cm at duodenoscopy,
the patient's poor medical fitness, age > 75 years and pre-
operative biopsy showing a pT1 cancer or adenoma of the
ampulla of Vater. In a patient less than 75 years of age, the
final histological examination showed a cancer more
advanced than pT1, but we did not proceed to pancreati-
coduodenectomy as his comorbidity contraindicated a
major operation. Finally, during local excision we per-
formed local lymph node dissection only if the nodes
were enlarged.
Pancreaticoduodenectomy is undoubtedly the procedure
of choice in the management of ampullary cancer in
patients who are medically fit, and this fact has been rein-
forced by the declining mortality after the procedure dur-
ing the past decades. This was also the policy in our study;
pancreaticoduodenectomy with or without pylorus pres-
ervation was the first choice of surgical treatment in
patients with tumors more advanced than pT1, unless it
was contraindicated by the patient's comorbidity or age
(>75 years), at which point a local excision was per-
formed. Hospital mortality after pancreaticoduodenec-
tomy is less than 5% in recently published series, whereas
the morbidity remains high and varies from 25 to 65%
[6,18-20,23]. The related mortality in our series was 0%
but morbidity was as high as 28.6%. The pattern of failure
after surgical resection for ampullary cancer is a crucial
point to assess the efficacy of adjuvant therapy for patients
receiving resection for cure. No patient in our study
received adjuvant chemotherapy and this is in accordance
with recent published studies showing no benefit of such
therapy after curative or non-curative resection of ampul-
lary cancer [24].
Survival after local resection it is difficult to estimate given
the small number of patients, but it has been reported to
be 40% to 50% at 5 years [25-29]. This figure is compara-
ble to 37.5% to 62.7% 5-year survival rate reported in the
much larger pancreaticoduodenectomy series [6,18-
20,23]. However, it is important to mention that the pan-
creaticoduodenectomy series included high-risk lesions
(T3 or T4, involved nodes, poor differentiation) which are
excluded from the local excision series, and this might be
an explanation for the comparable survival rates. In our
study which included a small number of patients, follow-
ing local excision of the ampullary cancer, the survival rate
at 3 and 5 years was 77.7% and 33.3% respectively.
Among the patients that underwent Whipple's procedure,
the 3-year survival rate was 76.2% and the 5-year survival
rate 62%.
Conclusion
In this series, local resection was a safe option in patients
with significant co-morbidity or small ampullary tumors
(<2 cm), and was associated with satisfactory long-term
survival rates.
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